1393727-02-0

Basic information

• Product Name: 7-(4-(4-acetylphenyl)piperazin-1-ylsulfonyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
• Synonyms: 7-(4-(4-acetylphenyl)piperazin-1-ylsulfonyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
• CAS NO: 1393727-02-0
• Molecular Weight: 427.524
• Mol File: 1393727-02-0.mol

Chemical Properties

• CAS DataBase Reference: 7-(4-(4-acetylphenyl)piperazin-1-ylsulfonyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(4-(4-acetylphenyl)piperazin-1-ylsulfonyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one(1393727-02-0)
• EPA Substance Registry System: 7-(4-(4-acetylphenyl)piperazin-1-ylsulfonyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one(1393727-02-0)

Safety Data

• Hazardous Substances Data: 1393727-02-0(Hazardous Substances Data)

Upstream product

• 927869-56-5 2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-7-sulfonyl chloride 
• 51639-48-6 4'-piperazinoacetophenone 

Relevant articles and documents

Discovery of a novel noniminosugar acid α glucosidase chaperone series

Pompe disease is an autosomal recessive lysosomal storage disorder (LSD) caused by deficiency of the lysosomal enzyme acid α-glucosidase (GAA). Many disease-causing mutated GAA retain enzymatic activity but are not translocated from endoplasmic reticulum